CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced it will present a corporate overview at the following investor conferences: Stifel 2020 Virtual Healthcare Conference on Monday, November 16, 2020 at 10:40 a.m. EST Jefferies Virtual London Healthcare Conference on Thursday, November 19, [...]